THE WHAT? Walgreens Boots Alliance has published its 2021 Environmental, Social and Governance Report.
THE DETAILS The drugstore chain’s highlights include Walgreens administering some 34.6 million COVID-19 vaccines, its Boots UK chain sending less than 1 percent of operational waste to landfill for a third consecutive year and reducing global carbon emissions by 14.9 percent from a 2019 baseline. The retail conglomerate also reported that it is on track to source 100 percent of palm oil from RSPO certified sources by the end of fiscal 2023.
THE WHY? CEO, Roz Brewer and Executive Stefano Pessina said in a statement, “For WBA, our corporate responsibility pillars – Healthy Communities, Healthy Planet, Healthy and Inclusive Workplace and Sustainable Marketplace – are at the heart of our purpose to create more joyful lives through better health. It’s what we believe. It’s what we do. It’s who we are.
“Our purpose is evident throughout this fiscal 2021 ESG Report, as we share the ongoing progress we’ve made on our sustainability targets and initiatives, and our diversity, equity and inclusion goals and our work to ensure health equity for all…
“We know that climate change is caused by human activities and we know it has negative impacts on human health. All companies must do their part to safeguard a liveable planet, and that is particularly important for us as a healthcare company.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
